[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1072 Introduced in House (IH)]
<DOC>
115th CONGRESS
2d Session
H. RES. 1072
Expressing support for the designation of September 2018 as ``Pulmonary
Fibrosis Awareness Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 20, 2018
Mr. Paulsen (for himself and Mr. Cohen) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of September 2018 as ``Pulmonary
Fibrosis Awareness Month''.
Whereas pulmonary fibrosis is a debilitating and ultimately fatal lung condition
that causes progressive scarring in the lungs and has no definitive
cause;
Whereas as many as 200,000 individuals in the United States are known to suffer
from pulmonary fibrosis, the majority of whom are aged 50 and older;
Whereas the average life expectancy from the diagnosis of the idiopathic form of
pulmonary fibrosis is just 2.8 years, and as many as 80 percent of
idiopathic pulmonary fibrosis patients die within 5 years of diagnosis;
Whereas pulmonary fibrosis takes the lives of 40,000 or more individuals in the
United States each year--approximately 1 individual every 13 minutes;
Whereas many patients afflicted with pulmonary fibrosis are misdiagnosed for 1
year or longer after the patients are presenting with pulmonary fibrosis
symptoms;
Whereas, as of July 2018, there are no confirmed biomarkers for screening and
testing for pulmonary fibrosis;
Whereas a cure, treatment, or drug to halt the fibrotic process in pulmonary
fibrosis does not yet exist;
Whereas the symptoms of pulmonary fibrosis vary from person to person and
include shortness of breath, a dry cough, fatigue, weight loss, and
aching muscles and joints;
Whereas volunteers, researchers, caregivers, and medical professionals are
working to improve the quality of life for individuals with pulmonary
fibrosis and for the families of those individuals; and
Whereas developing more effective treatments for pulmonary fibrosis and
providing access to quality care to individuals with pulmonary fibrosis
requires increased research, education, and community support services:
Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``Pulmonary Fibrosis
Awareness Month'';
(2) supports the goals and ideals of Pulmonary Fibrosis
Awareness Month;
(3) continues to support more robust and accelerated
research to develop more effective treatments for pulmonary
fibrosis and to ultimately find a cure for the disease;
(4) recognizes the courage and contributions of individuals
with pulmonary fibrosis who participate in vital clinical
trials to advance the knowledge of the disease; and
(5) commends the dedication of organizations, volunteers,
researchers, and millions of individuals in the United States
and abroad working to improve the quality of life for
individuals with pulmonary fibrosis and the families of those
individuals.
<all>